Matches in Nanopublications for { ?s ?p "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP742834.RATsEYLBH2KiE61gNM23F1L3W8pZs5aViYW9T4bInJ5SY130_assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742834.RATsEYLBH2KiE61gNM23F1L3W8pZs5aViYW9T4bInJ5SY130_provenance.
- assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP887700.RAjJ7MOktuymOUzrfYOMrJDqSBhK7RJd4lm8PJV8-OmDk130_assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887700.RAjJ7MOktuymOUzrfYOMrJDqSBhK7RJd4lm8PJV8-OmDk130_provenance.
- NP742803.RAEdwaMfOQkYXVTzKqYYmu_JhwG5pY6bKrTcK19c3w77E130_assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742803.RAEdwaMfOQkYXVTzKqYYmu_JhwG5pY6bKrTcK19c3w77E130_provenance.
- NP742825.RA7rmhk_JpYuolHgTA1pgHxD_mRC_zakK4zkRqPRz6Yd8130_assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742825.RA7rmhk_JpYuolHgTA1pgHxD_mRC_zakK4zkRqPRz6Yd8130_provenance.
- NP887702.RA5iY16OUsOpBizgaNpMGtF1_i5asuEDZLgP7LgTHqhdE130_assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887702.RA5iY16OUsOpBizgaNpMGtF1_i5asuEDZLgP7LgTHqhdE130_provenance.
- NP887705.RA7NUgWgop5pPxXAmOF-ojioUy_4jK4Hs_tz3Dv4DmTMc130_assertion description "[ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887705.RA7NUgWgop5pPxXAmOF-ojioUy_4jK4Hs_tz3Dv4DmTMc130_provenance.